Last reviewed · How we verify

NCT06774911: BIODISPROT

Evaluation of Amino Acids Bioavailability in a Food Product Based on a Vegetable Protein Combination

Completed NA Last updated 12 March 2025
What this trial tests

NA trial testing YUIT in Biological Availability in 12 participants. Completed in 4 March 2025.

Timeline
18 December 2024
Primary endpoint
4 March 2025
4 March 2025

Quick facts

Lead sponsorFundació Eurecat
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposeother
Enrollment12
Start date18 December 2024
Primary completion4 March 2025
Estimated completion4 March 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundació Eurecat

Who can join

Adults 18 to 50, any sex, with Biological Availability or Bioavailability and AUC. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Proteins can be classified as high or low biological value proteins depending on their composition in essential amino acids, which are those amino acids that the body cannot synthesize and must be provided through food. In recent years, there has been growing interest in reducing the consumption of proteins of animal origin, leading to the search for more sustainable protein options, such as vegetable proteins. However, vegetable options do not have a complete profile of essential amino acids. In this sense, soy protein is considered the reference vegetable protein because it has an adequate amino acid profile. However, the amount of methionine is considerably lower than that of an animal source, and it also has a considerable allergenic potential. The mixture of two types of complementary vegetable protein sources could serve as a strategy to achieve the profile of essential amino acids like that of an animal protein. The hypothesis of the present study is that the consumption of a mixture of vegetable proteins from legume and cereal sources will complement each other to achieve a bioavailability of essential amino acids equal to or greater than that observed when consuming soy protein.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Fundació Eurecat trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06774911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing